The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)

E-ISSN： 1873-5592|10|11|1118-1138

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.11, 2009-11, pp. : 1118-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT 1B/D Receptor Antagonists

By Pauwels P.J.

General Pharmacology, Vol. 29, Iss. 3, 1997-09 ,pp. : 293-303

Elsevier

Access to resources Recommend Favorite

Simultaneous blockade of 5-HT_1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT_1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B

By Hughes Zoë Starr Kathryn Scott Claire Newson Michael Sharp Trevor Watson Jeannette Hagan Jim Dawson Lee

Psychopharmacology, Vol. 192, Iss. 1, 2007-05 ,pp. : 121-133

Springer Publishing Company

Access to resources Recommend Favorite

The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT 1B/1D receptor agonist

By Gupta P. Butler P. Shepperson N.B. McHarg A.

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

5-HT_1B/1D antagonists and depression

By Halazy S. Lamothe M. Jorand-Lebrun C.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 339-352

Informa Healthcare

Access to resources Recommend Favorite

Serotonin Involvement in the Basal Ganglia Pathophysiology: Could the 5-HT2C Receptor be a New Target for Therapeutic Strategies?

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3069-3081

Bentham Science Publishers

Access to resources Recommend Favorite